Draft:Cetyl Tranexamate Mesylate

From Wikipedia, the free encyclopedia


Cetyl Tranexamate Mesylate (sold under the trade name TXVector™) is a bioavailable derivative of tranexamic acid for use in cosmetic formulations. Its primary use is in skincare products aimed at enhancing appearance by targeting hyperpigmentation, uneven skin tone, inflammation, dark spots, UV induced erythema, acne scars, and overall skin clarity.[1]

Structure[edit]

Cetyl Tranexamate Mesylate is a lipophilic ester and salt of the cyclic amino acid tranexamic acid. By esterification of the carboxylic acid group on tranexamic acid, the molecule loses its zwitterionic structure, becomes positively charged with enhanced skin permeability. Its lipophilic character and positive charge provide additional cosmetic benefits such as skin moisturization and powder-like feel.

One unique aspect of Cetyl Tranexamate Mesylate is that it is cationic and has cationic emulsification capability. Therefore it is always formulated into cationic emulsions, which in some cases to be superior to anionic emulsions for skin health and moisturization.[2][3]

Mechanism of Actions[edit]

Cetyl Tranexamate Mesylate is thought to act on the inflammatory pathway, reducing the melanogenesis and hyperpigmentation that is initiated by UV or acne inflammation. It differs from other hyperpigmentation actives, such as  hydroquinone and kojic acid, which are toxic to melanocytes and thus lighten or bleach all skin to which they are applied[4]. Cetyl Tranexamate Mesylate's selective targeting of inflamed melanin production, such as post-inflammatory hyperpigmentation (PIH) and acne-induced hyperpigmentation (AIH), may explain its popularity with users having dark skin tone.

Safety and Regulation[edit]

Cetyl Tranexamate Mesylate  is non-irritating and non-sensitizing in human studies. It is structural analogous to other lipophilic esters of amino acids which are readily biodegradable and non-toxic to the aquatic environment. Cetyl Tranexamate Mesylate is not on any country negative list for cosmetic products. However, it is not yet approved as a skin brightening active under the China cosmetics regulation (CSAR).

References[edit]

  1. ^ da Silva Souza, Ivan D.; Lampe, Lorraine; Winn, Daniel (February 2021). "New topical tranexamic acid derivative for the improvement of hyperpigmentation and inflammation in the sun-damaged skin". Journal of Cosmetic Dermatology. 20 (2): 561–565. doi:10.1111/jocd.13545. ISSN 1473-2130. PMID 32588531.
  2. ^ Tamburic, Slobodanka (2010-07-07), Tadros, Tharwat F. (ed.), "In Vivo Skin Performance of a Cationic Emulsion Base in Comparison with an Anionic System", Colloid Stability (1 ed.), Wiley, pp. 247–257, doi:10.1002/9783527631193.ch50, ISBN 978-3-527-31461-4, retrieved 2024-05-08
  3. ^ Tamburic, Slobodanka (2008-02-20), Tadros, Tharwat F. (ed.), "In Vivo Skin Performance of a Cationic Emulsion Base in Comparison with an Anionic System", Colloids in Cosmetics and Personal Care (1 ed.), Wiley, pp. 247–257, doi:10.1002/9783527631131.ch11, ISBN 978-3-527-31464-5, retrieved 2024-05-08
  4. ^ Kim, Minjeong; Lim, Kyung-Min (2022-10-01). "Melanocytotoxic chemicals and their toxic mechanisms". Toxicological Research. 38 (4): 417–435. doi:10.1007/s43188-022-00144-2. ISSN 2234-2753. PMC 9532501. PMID 36277364.